Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Cardiopulmonary Resuscitation III: AED Use

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...

Heart Failure Drugs: Inotropic Agents

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...

Heart Failure V: Medical Management

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

"Thumbnail Patch" Endoaneurysmorrhaphy Technique: Essentials for Modified Circular Repair of Left Ventricular Aneurysm.

Annals of thoracic surgery short reports·2026

Same author

Paving the Way for Less Invasive Femoral Arterial Decannulation in VA-ECMO: Advancing the Decannulation Paradigm.

The Annals of thoracic surgery·2025

Same author

Subaortic Obstruction due to Secondary Muscle Hypertrophy: A Hallmark or Predictor for Patient-Prosthesis Mismatch.

The Annals of thoracic surgery·2025

Same author

Competence by Design in Cardiac Surgery Resident Training: A Qualitative Thematic Analysis.

The Journal of surgical research·2025

Same author

New Insights on Albumin Use in Cardiac Surgery.

The Annals of thoracic surgery·2023

Same author

Invasive myocardial calcification of left ventricle associated with conduction disturbances, hypophosphatemia, and childhood rickets.

Anatolian journal of cardiology·2021

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

Ventricular assist device applications.

Kerem M Vural¹

¹Department of Cardiovascular Surgery, Türkiye Yüksek Ihtisas Hospital, Ankara, Turkey. kvural@tr.net

Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology

|December 11, 2008

Summary

This summary is machine-generated.

Mechanical circulatory support devices have advanced significantly since 1964. This review covers current ventricular assist systems and their clinical roles for heart failure patients.

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Experiment Videos

Last Updated: Jun 27, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Area of Science:

Cardiovascular Medicine
Biomedical Engineering
Medical Devices

Background:

The National Institutes of Health initiated the artificial-heart program in 1964.
Numerous circulatory support devices have been created for short-term use in end-stage heart failure.
Recent years have seen a surge in interest and development of mechanical ventricular assistance.

Purpose of the Study:

To review the evolution of ventricular assist devices.
To discuss current mechanical cardiac assist systems.
To examine the clinical application of these devices.

Main Methods:

Literature review of historical and current ventricular assist devices.
Analysis of technological advancements in mechanical cardiac assist.
Examination of clinical data and practices.

Main Results:

Significant technological and clinical progress in mechanical cardiac assist over the past decade.
A diverse range of ventricular assist devices are currently available and under development.
Established role of ventricular assist devices in managing end-stage heart failure.

Conclusions:

Ventricular assist device technology has rapidly evolved.
A wide array of devices exist, with ongoing development.
These devices play a crucial role in current clinical practice for heart failure management.